Cardiology Fellow @LaheyCardiology @LaheyHospital | Lahey IM alum | Wildlife Photography Enthusiast

Boston, MA
Joined October 2014
And Life starts now!! @LaheyMedicine @LaheyHospital
4
25
Rushin Patel MD retweeted
“Excited to share our latest editorial published in @CircAHA - Our study highlights T1 mapping as a novel marker for heart failure progression in hypertrophic cardiomyopathy (HCM). @EthanRowin @JAHA_AHA @AHAScience
2
5
1
40
3,980
Rushin Patel MD retweeted
In this #JACCCardioOnc study, Dr. @AmmarWB, et al highlight that #SGLT2 inhibitors 📉 the risk of CTRCD in pts w/ #T2DM & cancer, as well as lower #heartfailure exacerbations, mortality, & 🏥 jacc.org/doi/10.1016/j.jacca… #CardioOncology #SGLT2i @anita_deswal @AnaBaracCardio @JLiu_MSKCardOn @datsunian @RichardKCheng2 @TeresaLpezFdez @SumanthKhadkeMD @SarjuGanatraMD
2
32
68
8,548
Rushin Patel MD retweeted
New @JACCJournals #JACCHF In patients with #T2DM, ⬆️ #BMI & #HFpEF ➡️ #GLP1 agonists provide incremental benefit in addition to #SGLT2i with ⬇️ in: ▪️HF exacerbation ▪️All cause hospitalization ▪️Atrial arrhythmias ▪️Pulmonary HTN ▪️AKI DOI: 10.1016/j.jchf.2024.07.006
3
22
1
57
7,019
Rushin Patel MD retweeted
New #JACCHF 📄: bit.ly/40xnSB9 In patients w/ #Obesity, #T2DM & #HFpEF➡️#GLP1 agonists provide incremental benefits in addition to #SGLT2i w/ reduction in: 🔸HF exacerbation 🔸All-cause 🏥 🔸Atrial arrhythmias 🔸AKI 🔸Pulmonary #HTN @rushin311 @SarjuGanatraMD @LaheyResearch
22
2
62
10,886
As we enjoy #DiwaliCelebration, we’re committed to illuminating the path to better ❤️ heart 🏃‍♀️metabolic health for the South Asian community. 🌏 Thrilled to see @WBUR @Priyanka_Dayal recognizing unique need of the population & South Asian Cardio-Metabolic Programs wbur.org/news/2024/10/30/sou… Here’s to a healthier, brighter future! #HappyDiwali2024 @SaurabhSDani @smoffattbruce1 @jaideeppatelmd @pnatarajanmd @AmiBhattMD @alka_kanaya @AniruddhPatelMD @AnkurKalraMD @DrMarthaGulati @khurramn1 @LaheyHospital @LaheyCardiology @hopkinsheart @newtonwellesley @MGHHeartHealth @bethisraellahey
9
18
3
59
10,728
My comments re. future directions of #GLP1RA & #HeartFailureOutcomes | Efficacy of Semaglutide in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | comment: Rushin Patel MD prac.co/l/2a7wbaht @practiceupdate #DouglasZipes @mayocvonc #BenScirica
11
541
SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy #GCOS2024 @HemoncToday #CardioOncology @ACCinTouch Read more👇 healio.com/news/cardiology/2…
6
10
1,109
Rushin Patel MD retweeted
#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. bit.ly/4ebDU7t #GCOS24 #CardioOnc #Diabetes #T2D @AmmarWB @SarjuGanatraMD @AnaBaracCardio @datsunian @Richardkcheng2 @anita_deswal
1
54
2
111
18,409
Superb work by @LaheyCardiology stellar fellow @rushin311 and fantastic collaborators led by @SarjuGanatraMD !
This quoted post is unavailable.
5
34
2,457
Multi-Institute study in @JACCJournals led by @LaheyHospital investigators shows incremental benefits of #GLP1RA in addition to #SGLT2i for those with #heartfailure #HFpEF #obesity #diabetes sciencedirect.com/science/ar…
#SGLT2i and #GLP1 are both independently shown to benefit patients with #HFpEF #heartfailure But can #GLP1 provide incremental benefits to those already on #SGLT2i ? The answer is YES ✅️✅️✅️ For patients with #diabetes #HFpEF & #Obesity #realworlddata ➡️ Use of #GLP1 💉 ➕️ #SGLT2i💊 ⏬️ 🫀heart failure exacerbation ⏬️ 🏥 hospitalization & ER visits ⏬️ 💗 atrial fibrillation ⏬️ 🫁 Pulmonary hypertension ⏬️ Renal failure sciencedirect.com/science/ar… @JACCJournals @rushin311 @SaurabhSDani @JavedButler1 @DLBHATTMD @MkosiborodMD @gcfmd @Sadeer_AlKindi @Ashish_Kumar_MD @SumanthKhadkeMD @bhargavv_122 @AmmarWB @MarkWadid
1
5
17
1,544
#SGLT2i and #GLP1 are both independently shown to benefit patients with #HFpEF #heartfailure But can #GLP1 provide incremental benefits to those already on #SGLT2i ? The answer is YES ✅️✅️✅️ For patients with #diabetes #HFpEF & #Obesity #realworlddata ➡️ Use of #GLP1 💉 ➕️ #SGLT2i💊 ⏬️ 🫀heart failure exacerbation ⏬️ 🏥 hospitalization & ER visits ⏬️ 💗 atrial fibrillation ⏬️ 🫁 Pulmonary hypertension ⏬️ Renal failure sciencedirect.com/science/ar… @JACCJournals @rushin311 @SaurabhSDani @JavedButler1 @DLBHATTMD @MkosiborodMD @gcfmd @Sadeer_AlKindi @Ashish_Kumar_MD @SumanthKhadkeMD @bhargavv_122 @AmmarWB @MarkWadid
#Obesity 🔄 #HFpEF SGLT2i & GLP1RA independently benefit HFpEF. However, incremental benefits of both underexplored @JACCJournals study: #GLP1RA ➡️ incremental benefits in addition to #SGLT2i for pts with HFpEF, Obesity & T2DM
1
12
1
45
6,317
This Post is from an account that no longer exists. Learn more
3
6
2,829
#Obesity 🔄 #HFpEF SGLT2i & GLP1RA independently benefit HFpEF. However, incremental benefits of both underexplored @JACCJournals study: #GLP1RA ➡️ incremental benefits in addition to #SGLT2i for pts with HFpEF, Obesity & T2DM
1
32
3
91
25,271
Thank you to all my mentors and authors who helped make this project a success! @SarjuGanatraMD @SaurabhSDani @gcfmd @MkosiborodMD @Sadeer_AlKindi @DLBHATTMD @JavedButler1
1
7
590
What a fantastic time hosting the wonderful fellows, attending and leadership @LaheyMedicine @LaheyHospital @LaheyCardiology for the summer cookout! We look forward to a fabulous year ahead and many more occasions to celebrate!
1
8
72
4,484
Team of researchers led by @LaheyHospital in collaboration with @BrighamWomens @BIDMChealth @UCSFHospitals et al 🤝 to study the impact of #Paxlovid use for #COVID19 on the development of #LongCovid @rushin311 @SaurabhSDani @McQHoya81 @SumanthKhadkeMD @SarjuGanatraMD et al.
Nirmatrelvir plus ritonavir in nonhospitalized vaccinated patients with pre-existing #CVD with #COVID19 were associated with a reduction in PASC and health care utilization. bit.ly/3L5TrsD #JACCAdvances @rushin311 @SarjuGanatraMD
6
15
1,571
Rushin Patel MD retweeted
वंदे मातरम 🇮🇳
2,428
45,926
5,816
199,530
7,239,050